Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques

Frontiers in Immunology(2021)10.3389/fimmu.2021.621754Source: DataRank Database

Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.37)OA: goldTopics (59)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Grant C. Liao,Eunice Cho ORCID,Rajan P. Adhikari,Tom Kort,Frederick W. Holtsberg ORCID

Live enrichment

PubMed:33717122 PMC:PMC7947289 OpenAlex:https://openalex.org/W3134488415

NIAID NIH HHS

Grant: R01 AI111205

NIAID NIH HHS

Grant: HHSN272201200003I

Wellcome Trust

Grant: unidentified

unidentified

National Institutes of Health

Grant: 2R01AI111205-06

Multivalent Toxoid Vaccine for recurrent Staphylococccus aureus disease

Wellcome Trust

FWCI

0.37

Citation Percentile

0.6%

Citation Trend

2021

2022

2024

2025

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.621754/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.621754/pdf

journalhttps://doi.org/10.3389/fimmu.2021.621754

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33717122

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7947289

Fields of Study

Antimicrobial Resistance in StaphylococcusImmune Response and InflammationStreptococcal Infections and Treatments0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

Immunogenicity, VaccineBroadly Neutralizing AntibodiesAnimalsAntibodies, BacterialAntibody FormationLymphocyte ActivationMacaca mulattaStaphylococcal InfectionsStaphylococcal ToxoidStaphylococcal VaccinesVaccinationCD4-Positive T-LymphocytesSuperantigensMethicillin-Resistant Staphylococcus aureusImmunity, Heterologous

Keywords

ImmunogenicityImmunologyStaphylococcus aureusMedicineImmune systemSuperantigenVaccinationToxoidStaphylococcal infectionsAntigenVirologyToxic shock syndromeMicrobiologyImmunizationBiologyT cellBacteriaSafetyStaphylococcalNeutralizing AntibodiesMulti-componentCd4 T Cells ResponseCD4-Positive T-LymphocytesMethicillin-Resistant Staphylococcus aureusStaphylococcal ToxoidImmunity, HeterologousLymphocyte ActivationImmunogenicity, VaccineImmunology and AllergyAnimalsSuperantigensStaphylococcal VaccinesRC581-607Antibodies, BacterialMacaca mulattaAntibody FormationImmunologic diseases. AllergyBroadly Neutralizing Antibodies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being